The present data show that MPT0G013 inhibits angiogenesis by up-regulating TIMP3 gene expression in endothelial and tumor cells, indicating the potential of MPT0G013 as a therapeutic agent with dual activities against tumor growth and angiogenesis. Here, TIMP3 is linked to neoplasm.